calmidazolium has been researched along with bay-k-8644 in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 4 (57.14) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Matsumura, Y; Morimoto, S; Sasaki, Y; Shinyama, H; Uriu, T | 1 |
Barbieri, MA; Bertini, F; Isola, EL; Lammel, EM; Wilkowsky, SE | 1 |
McCullough, LA; Westfall, TC | 1 |
Ando, S; Clark, BJ; Pezzi, V; Rainey, WE; Stocco, DM | 1 |
Ando, S; Clyne, CD; Mathis, JM; Pezzi, V; Rainey, WE | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
7 other study(ies) available for calmidazolium and bay-k-8644
Article | Year |
---|---|
Inhibitory effects of calcium channel agonists on renin release from rat kidney cortical slices.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Dose-Response Relationship, Drug; Imidazoles; Ion Channels; Kidney Cortex; Male; Nifedipine; Pyridines; Rats; Rats, Inbred Strains; Renin; Trifluoperazine; Verapamil | 1987 |
Trypanosoma cruzi: involvement of intracellular calcium in multiplication and differentiation.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcimycin; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Chelating Agents; Chlorpromazine; Dopamine Antagonists; Egtazic Acid; Enzyme Inhibitors; Gallic Acid; Gallopamil; Imidazoles; Ionomycin; Ionophores; Morphogenesis; Triatoma; Trifluoperazine; Trypanosoma cruzi | 1996 |
Mechanism of catecholamine synthesis inhibition by neuropeptide Y: role of Ca2+ channels and protein kinases.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adenine; Animals; Calcium Channel Blockers; Calcium Channels; Calcium-Calmodulin-Dependent Protein Kinases; Carcinogens; Catecholamines; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Egtazic Acid; Enzyme Inhibitors; Imidazoles; Ion Channel Gating; Isoquinolines; Neuropeptide Y; Nifedipine; omega-Conotoxin GVIA; PC12 Cells; Peptides; Piperazines; Protein Kinase C; Protein Kinases; Protein Synthesis Inhibitors; Rats; Tetradecanoylphorbol Acetate; Thionucleotides | 1996 |
Role of calmodulin-dependent protein kinase II in the acute stimulation of aldosterone production.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenal Cortex; Aldosterone; Angiotensin II; Benzylamines; Bucladesine; Calcium Channel Agonists; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Calmodulin; Cell Line; Enzyme Inhibitors; Humans; Hydroxycholesterols; Imidazoles; Phosphoproteins; Potassium; Sulfonamides | 1996 |
Ca(2+)-regulated expression of aldosterone synthase is mediated by calmodulin and calmodulin-dependent protein kinases.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Benzylamines; Calcium; Calcium Channel Agonists; Calcium-Calmodulin-Dependent Protein Kinases; Calmodulin; Cell Line; Cytochrome P-450 CYP11B2; Enzyme Inhibitors; Gene Expression Regulation; Humans; Imidazoles; Ionomycin; Potassium; RNA, Messenger; Sulfonamides | 1997 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |